Sacral Nerve Stimulation ProcedureDescription, Latest Information and Doctors
Sacral Nerve Stimulation Overview
Learn About Sacral Nerve Stimulation
Cleveland Clinic Main Campus
Howard Goldman is a Urologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 39 years. Dr. Goldman is rated as an Elite provider by MediFind in Sacral Nerve Stimulation. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Urinary Incontinence, Stress Urinary Incontinence, Frequent or Urgent Urination, Sacral Nerve Stimulation, and Endoscopy. Dr. Goldman is board certified in American Board Of Urology, 2013.
Hillcrest Medical Building Atrium
Bradley Gill is a Urologist practicing medicine in Mayfield Hts, Ohio. He has been practicing medicine for over 19 years. Dr. Gill is rated as an Elite provider by MediFind in Sacral Nerve Stimulation. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Urinary Incontinence, Stress Urinary Incontinence, Enlarged Prostate (BPH), Sacral Nerve Stimulation, and Prostatectomy. Dr. Gill is board certified in American Board Of Urology, 2020.
Beachwood Family Health And Surgery Center
Raymond Rackley is a Urologist practicing medicine in Beachwood, Ohio. He has been practicing medicine for over 42 years. Dr. Rackley is rated as an Elite provider by MediFind in Sacral Nerve Stimulation. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Urinary Incontinence, Neurogenic Bladder, Stress Urinary Incontinence, Sacral Nerve Stimulation, and Ureteroscopy. Dr. Rackley is board certified in American Board Of Urology, 2015.
Summary: Fluoroscopy is performed when placing a lead during a sacral neuromodulation procedure. During lead placement, subjects will receive either conventional or experimental fluoroscopic settings. The radiation exposure will be compared between the two groups.
Summary: Single-arm study conducted in participants for the treatment of urinary urge incontinence in patients who have failed, could not tolerate, or were not a candidate for more conservative treatments. The objective of the study is to assess the effectiveness of 30-minutes daily therapeutic stimulation with the Neuspera System.


